Cue Biopharma appoints Pamela Garzone to board of directors

Cue Biopharma, Inc.

Pamela Garzone appointed to board effective April 19, 2023, following recommendation of committee.
Received option to purchase 40,000 shares vesting over three years.
Compensation per Director Compensation Policy; standard indemnification agreement.
No reportable transactions or arrangements with other persons.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Pamela Garzone

Director

CUE · Cue Biopharma, Inc.

Effective: 2023-04-19
Filed: April 25, 2023, 7:59 PM ET

On April 19, 2023, Pamela Garzone was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pamela Garzone was appointed as Director at Cue Biopharma, Inc..

Action: appointed
Role: Director

Exact text from the filing

On April 19, 2023, Pamela Garzone was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc.

View on SEC.gov

Cue Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-014246

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.